$PPHM Peregrine Pharmaceuticals, announced there r
Post# of 51
Posted On: 11/09/2015 12:11:57 PM
$PPHM Peregrine Pharmaceuticals, announced there results from multiple new preclinical studies demonstrating enhanced anti-tumor activity and immune activation for combinations of a preclinical bavituximab equivalent and checkpoint inhibitors such as anti-PD-1 and anti-CTLA-4 in preclinical models of breast cancer and melanoma.
Read More: http://investorshangout.com/post/view?id=3324...z3r10eOcg4
Read More: http://investorshangout.com/post/view?id=3324...z3r10eOcg4
(0)
(0)Avid Bioservices, Inc. (CDMO) Stock Research Links
Scroll down for more posts ▼